Navigation Links
Study: Surefire Medical's Technology Improves Delivery Of Embolics In Cancer Treatment
Date:3/6/2013

WESTMINSTER, Colo., March 6, 2013 /PRNewswire/ -- Surefire Medical's new infusion system maximizes delivery of drugs directly to the tumor site while minimizing potential damage to non-target organs, according to a new study.  The ability to more safely and efficiently deliver embolic agents to target tumors locally marks a significant advance in radiation oncology procedures and in the treatment of liver cancer.

The 29 procedure study, led by Steven Rose , M.D. of the University of California at San Diego Medical Center (UCSD) and reported in CardioVascular and Interventional Radiology, determined that when the unique Surefire expandable anti-reflux tip is deployed, an approximate 20 mm Hg pressure drop occurs downstream from the tip, causing a reversal of blood flow in arteries between the liver and adjacent organs.  This phenomenon prevents the chemoembolization or radioembolization agents from flowing into downstream non-target vessels. 

"These results show that the new catheter technology makes it possible to prevent embolics from traveling to distal non-target vessels," said Rose. "We may potentially see improved patient outcomes because all blood flow carrying the embolics is directed to the liver while protecting the rest of the body."

The Surefire catheter's unique expandable tip also enables more of the embolic agents to reach their intended destination.

"Dr. Rose has identified a unique property of the Surefire Infusion System that is not available with standard end-hole catheters," said Aravind Arepally , M.D., Surefire Medical's Chief Scientific Officer.  "This should provide additional arsenal for doctors performing liver directed therapies."

According to Rose, the Surefire Infusion System provides both upstream and downstream protection.

"We are extremely pleased that the growing body of clinical evidence, coupled with the enthusiasm of our increasing user base at hospitals worldwide, continues to prove the efficacy of the Surefire line of catheters," said Surefire Medical CEO Jim Chomas .

About Surefire Medical

Surefire Medical, Inc., based in Westminster, Colo., was founded in 2009 to develop innovative infusion systems for the interventional radiology and interventional oncology markets.  Surefire's infusion systems are designed to precisely deliver embolic agents through a unique microcatheter with an expandable tip that collapses in forward flow and dynamically expands to the vessel wall in reverse flow in order to maximize targeted delivery, minimize reflux and reduce damage to healthy tissue.  For more information, please visit www.surefiremedical.com.

 


'/>"/>
SOURCE Surefire Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. National Study: Teen "Heavy" Marijuana Use Up 80 Percent Since 2008, One in Ten Teens Reports Using Marijuana at Least 20 Times a Month
2. Inaugural Harris Poll Physician Pulse(SM) Study: Viagra® and Cialis® are Highest Ranked in Trust
3. Clinical Study: Dietary Supplement SagaPro Reduces Frequent Urination
4. WebMD Study: U.S. Doctors Deeply Divided on Many Matters of Ethical Ambiguity
5. Prostate Cancer Study: Most Patients Report Satisfaction After Robotic Surgery
6. Surefire Medical Receives FDA Clearance For High-Flow Microcatheter
7. Surefire Medicals Infusion System For Embolization Procedures Receives CE Mark Approval
8. Christopher Mennone Joins Surefire Medical Team As International Business Director
9. Surefire Medical, Inc.: Gene McGrevin Joins Surefire Medicals Board of Directors
10. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
11. Fujitsu to Showcase Radiation-Hardened RFID Using FRAM Technology at Interphex 2012 in New York City, Booth #2430
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform ... published the first annual edition of its Global CSR Risk and Performance ... evaluated by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data ... ... ...
(Date:9/9/2017)... Dealmed Medical Supplies, New York ... supplies, drugs, vaccines, and specialty medical products and services, ... to acquire Vantage Medical Supplies, a major distributor of ... New York . ... medical practices, will operate under the Dealmed name as ...
(Date:9/7/2017)... , Sept. 7, 2017 Caris ... focused on fulfilling the promise of precision medicine, ... validate the benefits of its molecular profiling approach ... utilized comprehensive genomic profiling plus (CGP+) with Caris ... patient,s tumor on a molecular level, leading to ...
Breaking Medicine Technology:
(Date:9/22/2017)... ... September 22, 2017 , ... PITTSBURGH...Defibrillators are used ... lives. However, if one isn’t accessible in certain locations, the risk of death ... came up with this idea," said an inventor from Ridgecrest, Calif. , The ...
(Date:9/22/2017)... ... September 22, 2017 , ... Ecocor , a construction ... Architect (RPA), a full-service architecture firm focusing on sustainable design, have announced ... Model Homes . Independently, Ecocor and RPA have extensive experience with site-built and ...
(Date:9/22/2017)... ... September 22, 2017 , ... Tiny Transitions ... pleased to offer in-home and online newborn sleep consultations . , “We ... the body,” says company owner Courtney Zentz, a pediatric sleep professional, post-partum doula ...
(Date:9/22/2017)... ... September 22, 2017 , ... Happy Living’s mission - to improve the health ... into the entertaining and delicious worlds of theatre and wines. , After watching ... him to turn his play into a book. The Greener The Grass ( https://www.happyliving.com/books/the-greener-the-grass ...
(Date:9/22/2017)... ... September 22, 2017 , ... “Cursed with a ... obligatory tithe, and the freedom experienced when breaking free from this misconception. “Cursed ... Lysa M. Harrison. , Published by Christian Faith Publishing, Lysa M. Harrison’s new ...
Breaking Medicine News(10 mins):